Cited by 1,179Cancer, Hypoxia, and MetabolismCancer Cells and MetastasisAngiogenesis and VEGF in Cancer

Hypoxia-Inducible Factors, Stem Cells, and Cancer

Open access
Keith, Brian, Simon, M. Celeste·2007·Cell

Abstract

Regions of severe oxygen deprivation (hypoxia) arise in tumors due to rapid cell division and aberrant blood vessel formation. The hypoxia-inducible factors (HIFs) mediate transcriptional responses to localized hypoxia in normal tissues and in cancers and can promote tumor progression by altering cellular metabolism and stimulating angiogenesis. Recently, HIFs have been shown to activate specific signaling pathways such as Notch and the expression of transcription factors such as Oct4 that control stem cell self renewal and multipotency. As many cancers are thought to develop from a small number of transformed, self-renewing, and multipotent "cancer stem cells," these results suggest new roles for HIFs in tumor progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2007.04.019

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The stem cell-like state is mediated by upregulation of OCT4, Notch, c-Myc, and telomerase.

    “The stem cell-like state is mediated by upregulation of OCT4, Notch, c-Myc, and telomerase (Keith & Simon, 2007).”

    From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Keith & Simon, 2007

    Figure 3 proposes that HIF activity in some hypoxic tumor cells could enhance the activity or expression of Notch, Oct4, c-Myc, and telomerase, potentially contributing to stem cell-like properties. The claim overstates this proposed mechanism as established and describes all four as upregulated, whereas the figure says their activity or expression could be enhanced. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • HIF activation drives tumor progression by coordinating transcriptional programs that promote glycolytic metabolism, angiogenic factor production, cell survival, proliferation, immune evasion, and maintenance of cancer stem-like properties.

    “From a mechanistic standpoint, HIF activation drives tumor progression by coordinating transcriptional programs that promote glycolytic metabolism, angiogenic factor production, cell survival, proliferation, immune evasion, and maintenance of cancer stem like properties [20,250,251].”

    From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [251]

    The author manuscript and Figure 1 describe HIF-regulated genes involved in glycolysis and angiogenesis, while the cancer-stem-cell section discusses effects on survival and context-dependent proliferation. But Figure 3 presents acquisition of stem-like properties as a proposed model, not established maintenance, and the passages found do not link HIF activation to immune evasion. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 59 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Cowden Dahl KD, Fryer BH, Mack FA, Compernolle V, Maltepe E, Adelman DM, Carmeliet P, Simon MC. Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation. Mol Cell Biol. 2005; 25:10479-10491. [PubMed: 16287860]

Cited by

Sorted by citations

Authors
Keith, B., & Simon, M. C.
Affiliations
  • University of Pennsylvania (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • Keith, Brian
  • Simon, M. Celeste
Venue
Cell
Publisher
Elsevier BV
Published
2007-05
Volume
129
Issue
3
Pages
465-472
ISSN
0092-8674 (ISSN-L)
OpenAlex
W1973541913
Cited by
1,179
References
59
Citations by year
2026: 32 · 2025: 49 · 2024: 54 · 2023: 49 · 2022: 68 · 2021: 62 · 2020: 62 · 2019: 58 · 2018: 62 · 2017: 74 · 2016: 63 · 2015: 81 · 2014: 84 · 2013: 80 · 2012: 72
FWCI
4.58
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (HL66130, R01HL066130)
  • Core Research for Evolutional Science and Technology
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
hypoxia-inducible factor, tumor hypoxia, cancer stem cells, stem cell self-renewal, tumor angiogenesis, Notch signaling, Oct4, tumor progression, cellular metabolism, transcriptional regulation
MeSH terms
Animals, Hypoxia, Humans, Neoplasms, Stem Cells, Neoplastic Stem Cells, Signal Transduction, Cell Hypoxia, Disease Progression, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review